Dosing Guide

What Do I Do When I Miss My Peptide Injection?

Missing a dose is one of the most common questions in peptide research, and the honest answer is reassuring: most peptide protocols are forgiving. Here is a practical playbook for the four most common scenarios, plus the one rule that applies to every situation.

The one rule:

Never double the next dose to make up for a missed one. Doubling amplifies side-effect risk without meaningfully improving results, and it disrupts the steady-state that most peptides rely on.

Missed by a few hours (same day)

Take the dose as soon as you remember. Keep your next scheduled dose at its normal time. For most research peptides — BPC-157, TB-500, GHK-Cu, ipamorelin — a few hours of timing variance has no practical impact on outcomes.

Missed by a full day

Skip the missed dose entirely. Take your next dose at the usual scheduled time. Do not double up to compensate. Doubling rarely improves results and increases the chance of side effects (especially for GH secretagogues like ipamorelin and CJC-1295, where higher single doses can amplify water retention or transient hunger).

Missed multiple days during a cycle

Resume your normal dosing schedule from today. There is no benefit to extending the cycle by the number of missed days for healing peptides — the rolling steady-state matters more than total exposure. For longevity protocols (Epitalon, Thymalin) where total cumulative dose is part of the protocol, you can simply tack the missed doses onto the end of the cycle.

Forgot mid-cycle for a week or more

Treat the cycle as ended. Restart the protocol from day 1 if you still want full benefit, or simply move on to your normal washout period. Inconsistent dosing produces inconsistent results, and a clean restart gives you cleaner data for whatever you are tracking.

Why peptides are forgiving

Most research peptides have short half-lives (BPC-157 is roughly four hours; ipamorelin around two; CJC-1295 with DAC is several days). What matters for outcomes is the cumulative receptor exposure over a cycle, not the precision of any individual injection. Missing one dose in a four-week protocol changes total exposure by less than 1%.

There is one notable exception: long-acting analogues with strict weekly schedules (semaglutide, tirzepatide, retatrutide). These are designed around weekly steady-state pharmacokinetics. If you miss one of these, the published guidance is to take the missed dose within five days of the original schedule; otherwise skip it and resume your normal day. Never compress doses closer than five days apart.

Track to avoid missing

• Use a phone reminder set to your typical injection time.
• Keep your reconstituted vial visible in the fridge so it acts as a daily cue.
• Write the cycle start date on a calendar — visual tracking is more reliable than memory.
• If you frequently forget, it is a signal to simplify the protocol or shift to a longer-acting peptide.

Related guides: